Apixaban and Dalteparin: Interaction Details
- Apixaban
- EliquisELIQUIS 30-Day Starter PackEliquis Sprinkle
- Dalteparin
- Fragmin
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Apixaban and Dalteparin interaction:
Apixaban
- Eliquis
- ELIQUIS 30-Day Starter Pack
- Eliquis Sprinkle
Dalteparin
- Fragmin
We don't have a drug information page for Dalteparin yet. Have a question about Dalteparin? Ask a pharmacist, free →
What Happens When You Take Apixaban With Dalteparin
What can happen when they are taken together (rated Major)
An increased risk of bleeding and can cause serious, potentially fatal bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Giving apixaban, a factor Xa , together with another raises the likelihood of bleeding. interaction studies with apixaban showed that anti-factor Xa activity rose by 50% to 60% when apixaban and enoxaparin were administered concurrently.
Apixaban should be stopped if active pathological bleeding develops. A product capable of reversing apixaban's anti-factor Xa activity is on the market.
Apixaban's pharmacodynamic effect is anticipated to remain for at least 24 hours following the final dose. Patients should be counseled on the signs and symptoms of blood loss and told to report them without delay or to present to an emergency room.
Prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa may be considered. If PCCs are given, tracking apixaban's anticoagulant effect through a clotting test (PT, , or aPTT) or anti-factor Xa (FXa) activity offers no benefit and is not advised. of apixaban is reduced by activated oral charcoal, which in turn decreases apixaban exposure.1
The Apixaban and Dalteparin Interaction, Explained
Both of these medicines are . Apixaban (Eliquis) and dalteparin (Fragmin) each slow down your blood's ability to clot, just in slightly different ways. When you take them together, that effect adds up, so your risk of bleeding goes higher. That can range from easy bruising to serious bleeding that needs emergency care.
Sometimes doctors do use two blood thinners on purpose for a short time, so this isn't always a mistake. The important thing is that your care team is watching. Watch for signs like unusual bruising, pink or red urine, black stools, nosebleeds that won't stop, or feeling dizzy and weak. If you notice any of these, get help right away.
anticoagulation. Apixaban is a direct factor Xa and dalteparin is a low-molecular-weight heparin that also inhibits factor Xa (via antithrombin). produces additive anti-Xa effect and increased bleeding risk.
- Direction: increased effect (neither is a ).
- Magnitude: PD studies with apixaban plus enoxaparin showed a 50 to 60% rise in anti-Xa activity; expect a comparable additive effect with dalteparin.
- Evidence/severity: probable mechanism, major severity.
- Management: avoid overlap unless clinically indicated; monitor for bleeding. Discontinue apixaban if active pathological bleeding occurs. A reversal agent for apixaban anti-Xa activity is available; PCC, aPCC, or rVIIa may be considered. Apixaban PD effect persists at least 24 hours after the last dose.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Apixaban and Dalteparin Interact
The likely mechanism
anticoagulation
How to Manage the Apixaban and Dalteparin Interaction
Take both exactly as prescribed and do not stop either one on your own. If your team has you on both, they are usually doing so deliberately and will watch you closely.
- Learn the warning signs of bleeding: unusual or large bruises, blood in urine or stool (or black, tarry stools), coughing or vomiting blood, severe headache, or unusual weakness and dizziness.
- Report any of these right away, or go to an emergency room.
- Your care team may adjust and individualize your doses and monitor you more closely while you are on both.
- Ask your pharmacist or prescriber to confirm how long you should be on both together.
Reassuringly, a reversal agent for apixaban is available if serious bleeding occurs.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Apixaban or Dalteparin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: ELIQUIS oral film coated tablets, apixaban oral film coated tablets
In investigations of drug interactions involving apixaban, a 50% to 60% rise in anti-factor Xa activity was seen when apixaban and enoxaparin were given together.1
Apixaban and Dalteparin: Common Questions
How serious is the Apixaban and Dalteparin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Apixaban and Dalteparin interaction managed?
Take both exactly as prescribed and do not stop either one on your own. If your team has you on both, they are usually doing so deliberately and will watch you closely. Learn the warning signs of bleeding: unusual or large bruises, blood in urine or stool (or black, tarry stools), coughing or vomiting blood, severe headache, or unusual weakness and dizziness. Report any of these right away, or go… Management is individual — always follow your own care team's guidance.
How far apart should I take Apixaban and Dalteparin?
The interaction record says to take apixaban at least 24 hours after dalteparin.
Your pharmacist can help you fit this into the times you take your other medicines.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Apixaban and Dalteparin Interaction
Ask in your own words about taking Apixaban and Dalteparin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
Other Serious Interactions of Apixaban and Dalteparin
Also serious with Apixaban
Also serious with Dalteparin
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Apixaban
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- PiracetamMajor
- Vitamin EModerate
- SeleniumModerate
- GingerModerate
- TurmericModerate
- + 284 more
With Dalteparin
- Activated CharcoalMajor
- PiracetamMajor
- Vitamin EModerate
- SeleniumModerate
- GingerModerate
- TurmericModerate
- CaffeineModerate
- Green TeaModerate
- + 215 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.